Skip to main content
. 2015 Jun 23;6(27):23857–23873. doi: 10.18632/oncotarget.4408

Figure 5. Combined treatment of lovastatin and gefitinib induced antitumor growth activity of human intrahepatic cholangiocarcinoma SSP-25 and HuH-28 cells grown in MTAMs and cultivated in mice.

Figure 5

A. Schematic representation of the experiment. SSP-25 or HuH-28 cells (1 × 105 cells/mL) grown in MTAMs were implanted subcutaneously into mice for 72 hours, treated with drugs, and then harvested at 72 hours for B. the MTT assays, C. RT-PCR. Student's t test was conducted and considered significant at p < 0.05 (*).